P

Inventor

YEUNG KAP-SUN

US54 patents
⚠️ This page may combine multiple inventors who share the name “YEUNG KAP-SUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

38 patents
US7745625B2Jun 29, 2010

Prodrugs of piperazine and substituted piperidine antiviral agents

BRISTOL MYERS SQUIBB CO62 citations97
US9308236B2Apr 12, 2016

Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions

BRISTOL MYERS SQUIBB CO51 citations96
US6469006B1Oct 22, 2002

Antiviral indoleoxoacetyl piperazine derivatives

BRISTOL MYERS SQUIBB CO96 citations95
US9879046B2Jan 30, 2018

Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions

BRISTOL MYERS SQUIBB CO17 citations93
US7994171B2Aug 9, 2011

Compounds for the treatment of hepatitis C

BRISTOL MYERS SQUIBB CO20 citations92
US7473688B2Jan 6, 2009

Indolobenzazepine HCV NS5B inhibitors

BRISTOL MYERS SQUIBB CO26 citations92
US7452876B2Nov 18, 2008

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

BRISTOL MYERS SQUIBB CO21 citations92
US7348337B2Mar 25, 2008

Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides

BRISTOL MYERS SQUIBB CO37 citations92
US6825201B2Nov 30, 2004

Indole, azaindole and related heterocyclic amidopiperazine derivatives

BRISTOL MYERS SQUIBB CO46 citations92
US10143746B2Dec 4, 2018

Immunomodulators

BRISTOL MYERS SQUIBB CO9 citations84
US9850225B2Dec 26, 2017

Compounds useful as immunomodulators

BRISTOL MYERS SQUIBB CO13 citations84
US8048887B2Nov 1, 2011

Compounds for the treatment of hepatitis C

BRISTOL MYERS SQUIBB CO17 citations84
US7547690B2Jun 16, 2009

Compounds for the treatment of Hepatitis C

BRISTOL MYERS SQUIBB CO8 citations84
US7541353B2Jun 2, 2009

Compounds for the treatment of hepatitis C

BRISTOL MYERS SQUIBB CO11 citations84
US7538102B2May 26, 2009

Compounds for the treatment of Hepatitis C

BRISTOL MYERS SQUIBB CO16 citations84
US7521441B2Apr 21, 2009

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

BRISTOL MYERS SQUIBB CO18 citations84
US7521444B2Apr 21, 2009

Compounds for the treatment of hepatitis C

BRISTOL MYERS SQUIBB CO17 citations84
US10538555B2Jan 21, 2020

Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions

BRISTOL MYERS SQUIBB CO8 citations83
US8871771B2Oct 28, 2014

Salts of prodrugs of piperazine and substituted piperidine antiviral agents

BRISTOL MYERS SQUIBB CO5 citations83
US9850283B2Dec 26, 2017

Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions

BRISTOL MYERS SQUIBB CO12 citations82
US11578054B2Feb 14, 2023

Compounds useful as immunomodulators

BRISTOL MYERS SQUIBB CO2 citations73
US11046675B2Jun 29, 2021

Substituted isoquionline derivatives as immunomudulators

BRISTOL MYERS SQUIBB CO4 citations73
US10144706B2Dec 4, 2018

Compounds useful as immunomodulators

BRISTOL MYERS SQUIBB CO7 citations73
US10882844B2Jan 5, 2021

Compounds useful as immunomodulators

BRISTOL MYERS SQUIBB CO4 citations72
US9738653B2Aug 22, 2017

Fused furans for the treatment of hepatitis C

BRISTOL MYERS SQUIBB CO3 citations72
US9096580B2Aug 4, 2015

Benzofuran derivatives for the treatment of hepatitis C

BRISTOL MYERS SQUIBB CO3 citations63
US7998951B2Aug 16, 2011

HCV NS5B inhibitors

BRISTOL MYERS SQUIBB CO2 citations63
US10745382B2Aug 18, 2020

Compounds useful as immunomodulators

BRISTOL MYERS SQUIBB CO2 citations62
US10590105B2Mar 17, 2020

1,3-dihydroxy-phenyl derivatives useful as immunomodulators

BRISTOL MYERS SQUIBB CO2 citations62
US8722688B2May 13, 2014

Compounds for the treatment of hepatitis C

BRISTOL MYERS SQUIBB CO2 citations62
US7652004B2Jan 26, 2010

Compounds for the treatment of hepatitis C

BRISTOL MYERS SQUIBB CO4 citations62
US8039486B2Oct 18, 2011

Indole, azaindole and related heterocyclic N-substituted piperazine derivatives

BRISTOL MYERS SQUIBB CO3 citations61
US7915283B2Mar 29, 2011

Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides

BRISTOL MYERS SQUIBB CO3 citations61
US11414418B2Aug 16, 2022

Compounds useful as immunomodulators

BRISTOL MYERS SQUIBB CO0 citations52
US9556162B2Jan 31, 2017

Compound for the treatment of hepatitis C

BRISTOL MYERS SQUIBB CO0 citations52
US9303020B2Apr 5, 2016

Compounds for the treatment of hepatitis C

BRISTOL MYERS SQUIBB CO1 citations52
US8354410B2Jan 15, 2013

Compounds for the treatment of hepatitis C

BRISTOL MYERS SQUIBB CO1 citations52
US11161837B2Nov 2, 2021

Benzofuran derivatives for the treatment of hepatitis C

BRISTOL MYERS SQUIBB CO0 citations47

YEUNG KAP-SUN

4 patents

PRACITTO RICHARD

3 patents

UEDA YASUTSUGU

2 patents

BRISTOL MYERS SQIBB COMPANY

1 patent

VIIV HEALTHCARE UK NO 4 LTD

1 patent

KIM KYOUNG S

1 patent

Showing the top 50 of 54 patents by PatentIndex Score.